Skip to Content
<< Back
Quality Systems, Inc. Reports Fiscal 2013 Fourth Quarter and Year-End Results
May 23, 2013 at 5:00 AM EDT

Company Also Appoints Michael Aghajanian to Board of Directors

IRVINE, Calif.--(BUSINESS WIRE)-- Quality Systems, Inc. (NASDAQ:QSII) announced today results for its fiscal 2013 fourth quarter and year ended March 31, 2013.

The Company reported revenues of $460.2 million for the fiscal year ended March 31, 2013, an increase of 7 percent versus $429.8 million for the 2012 fiscal year ended March 31, 2012. Net income for fiscal 2013 was $42.7 million, a decrease of 44 percent when compared with net income of $75.7 million for fiscal 2012. Fully diluted earnings per share for the 2013 fiscal year was $0.72, down 44 percent from $1.28 for the 2012 fiscal year.

Revenues for the fiscal 2013 fourth quarter reached $111.3 million, up 2 percent when compared with $109.0 million for the fourth quarter of the previous fiscal year.

In light of recent operating results of the Company's Hospital Division, management performed a comprehensive operational review of that business unit in the latter part of the fourth quarter and, accordingly, revised its operating plans to incorporate additional investment in development, implementation and support. This investment will initially impact near-term profitability of the unit. Management is committed to realizing the substantial opportunity it perceives exists in the small hospital market and is confident in the strength its product and service offerings bring to the sector. As a result of this operational review and an updated assessment of the fair value of the business unit's goodwill, the Company recorded a goodwill impairment charge to income of $17.4 million for the fiscal 2013 fourth quarter.

Net loss for the fiscal 2013 fourth quarter was $4.1 million versus net income of $15.1 million for the comparable period a year ago. Fully diluted loss per share was ($0.07) in the fourth quarter of fiscal 2013 versus earnings per share of $0.25 for the fourth quarter of fiscal 2012. Excluding the impairment charge, pro forma net income for fiscal 2013 was $59.1 million with fully diluted earnings per share of $0.99. Pro forma net income for the fourth quarter of fiscal 2013 was $12.3 million with fully diluted earnings per share of $0.21.

"We are moving forward with the reorganizational plan we put in place during fiscal 2013, and are increasing our opportunities to leverage cross selling, especially on the RCM Services side. We also saw positive momentum in our bookings of products and services during the fourth quarter, including record RCM bookings, which is affording us a great start in the new fiscal year," said Steven T. Plochocki, president and chief executive officer.

"While this takes time, we are confident in our growth strategy and our ancillary products and services that cater to today's changing healthcare models," Plochocki concluded.

In other news, Quality Systems reported that Michael Aghajanian was appointed to its Board of Directors, effective May 22, 2013. Aghajanian fills one of the two vacancies on the Board after recent resignations of two board members. Aghajanian was also appointed to serve on the Board's Transaction Committee.

Aghajanian, age 55, brings more than 30 years of engineering and operational experience to the company. He is an adjunct professor in the engineering department at Worcester Polytechnic Institute ("WPI") and a frequent lecturer and supporter of the Office of Executive Education at the Paul Merage School of Business at the University of California, Irvine ("UCI"). Previously, Aghajanian held a variety of roles of increasing responsibility at Pittiglio Rabin Todd & McGrath ("PRTM"), a management consultant company providing services in the areas of operational strategy, supply chain management, product innovation and customer experience excellence, culminating in his role as President and Chief Executive Officer. In addition to his educational work with WPI and UCI, since his retirement from PRTM, Aghajanian has served on the board of directors of several for-profit and charitable organizations, including serving as the Chairman of Cimtek, Inc., a provider of functional testing of electronics, and on the boards of directors of Nexiant, Inc., a provider of MRO inventory solutions, and the Orange County Technology Action Network, an organization devoted to fueling technology growth in Orange County, Calif.

Aghajanian earned a Master's degree in Business Administration with a concentration in technology management from the University of California, Irvine and a Bachelor of Science in engineering from Worcester Polytechnic Institute in Massachusetts.

"We welcome Michael to our Board. His operational and leadership experience as well as his expertise in strategic direction will prove beneficial, particularly during a time of refocus as we reorganize the Company to take better advantage of opportunities within the changing healthcare landscape. We look forward to Michael's contributions," Plochocki noted.

Quality Systems also announced that its Board of Directors declared a quarterly cash dividend of seventeen and one-half cents ($0.175) per share on the Company's outstanding shares of common stock, payable to shareholders of record as of June 14, 2013 with an anticipated distribution date of July 5, 2013. The $0.175 per share cash dividend is pursuant to the Company's current policy to pay a regular quarterly dividend on the Company's outstanding shares of common stock, subject to further Board review and approval, and establishment of record and distribution dates by the Board prior to the declaration and payment of each such quarterly dividend.

The Company will hold its 2013 Annual Shareholders' Meeting on Thursday, August 15, 2013 at 1:00 PM local time. The meeting will be held at The Irvine Marriott, 18000 Von Karman Avenue, Irvine, Calif., 92612. Holders of record as of June 17, 2013 are eligible to vote and attend. Proxy materials and the 2013 Annual Report will be made available to shareholders of record and will also be posted on the Company's website at

Quality Systems will host a conference call to discuss its fiscal 2013 fourth quarter and year-end results on Thursday, May 23, 2013 at 10:00 AM ET (7:00 AM PT). All participants should dial 1-877-941-6010 at least ten minutes prior to the start of the call. International callers should dial 1-480-629-9643. To hear a live Web simulcast or to listen to the archived webcast following completion of the call, please visit the Company's website at, click on the "Investors" tab, then select "Conference Calls," to access the link to the call. To listen to a telephone replay of the conference call, please dial 800-406-7325 or 303-590-3030 and enter reservation identification number 4620344. The replay will be available from approximately 12:00 PM ET on Thursday, May 23, 2013, through 11:59 PM ET on Thursday, May 30, 2013.

A transcript of the conference call will be made available on the Company's website at

About Quality Systems, Inc.

Irvine, Calif.-based Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. Visit and for additional information.


This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue, net income and earnings per share). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2012, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.


This news release contains certain non-GAAP (Generally Accepted Accounting Principles) financial measures which are provided only as supplemental information. Investors should consider these non-GAAP financial measures only in conjunction with the comparable GAAP financial measures. These non-GAAP measures are not in accordance with or a substitute for, U.S. GAAP. Pursuant to the requirements of Regulation G, the Company has provided a reconciliation of non-GAAP financial measures to the most directly comparable financial measure in the accompanying financial tables. Other companies may calculate non-GAAP measures differently than Quality Systems, which limits comparability between companies.

The Company believes that its presentation of non-GAAP measures, such as pro forma net income and Days Sales Outstanding ("DSO"), provides useful supplemental information to investors and management regarding the Company's financial condition and results. Pro forma net income is calculated by excluding the goodwill impairment charge from net income (loss) before provision for income taxes and the product is adjusted pre-tax income. From the adjusted pre-tax income amount, the tax provision (excluding the tax effect of the impairment) is deducted and the result is pro forma net income. The Company calculates DSO as follows: net revenue for the quarter is annualized (multiplied by four) and then divided by 365 days to yield an average daily sales amount. The balance of accounts receivable, net of any reserves for bad debts, is then divided by that average daily sales amount resulting in the DSO.


Three Months Ended March 31,

Year Ended March 31,
  2013         2012   2013         2012  


Software, hardware and supplies $ 17,109 $ 26,562 $ 88,572 $ 122,407
Implementation and training services   7,161     8,270   35,008     26,391  
System sales 24,270 34,832 123,580 148,798
Maintenance 40,025 35,871 156,771 138,832
Electronic data interchange services 15,653 13,081 59,709 49,259
Revenue cycle management and related services 15,317 11,402 59,219 45,572
Other services   16,030     13,808   60,950     47,374  
Maintenance, EDI, RCM and other services   87,025     74,162   336,649     281,037  
Total revenues   111,295     108,994   460,229     429,835  
Cost of revenue:
Software, hardware and supplies 5,695 4,976 21,750 18,399
Implementation and training services   7,023     6,179   30,896     21,298  
Total cost of system sales 12,718 11,155 52,646 39,697
Maintenance 5,505 4,844 20,316 17,104
Electronic data interchange services 10,099 8,606 38,350 32,422
Revenue cycle management and related services 10,980 8,608 43,324 34,295
Other services   8,995     8,728   35,016     27,705  
Total cost of maintenance, EDI, RCM and other services   35,579     30,786   137,006     111,526  
Total cost of revenue   48,297     41,941   189,652     151,223  
Gross profit 62,998 67,053 270,577 278,612
Operating expenses:
Selling, general and administrative 38,308 34,195 148,353 128,846
Research and development costs 8,231 8,907 30,865 31,369
Amortization of acquired intangible assets 1,194 653 4,859 2,198
Impairment of goodwill   17,400     -   17,400     -  
Total operating expenses   65,133     43,755   201,477     162,413  
Income (loss) from operations (2,135 ) 23,298 69,100 116,199
Interest income (expense) (93 ) 35 (107 ) 247
Other income (expense), net   36     261   (79 )   (139 )
Income (loss) before provision for income taxes (2,192 ) 23,594 68,914 116,307
Provision for income taxes   1,898     8,521   26,190     40,650  
Net income (loss) $ (4,090 ) $ 15,073 $ 42,724   $ 75,657  
Net income (loss) per share:
Basic $ (0.07 ) $ 0.26 $ 0.72 $ 1.29
Diluted $ (0.07 ) $ 0.25 $ 0.72 $ 1.28
Weighted average shares outstanding:
Basic 59,541 59,048 59,392 58,729
Diluted 59,541 59,232 59,462 59,049
Dividends declared per common share $ 0.175 $ 0.175 $ 0.700 $ 0.700
Proforma net income * $ 12,292   $ 59,106  
Proforma net income per diluted share $ 0.21 $ 0.99
* Net income excluding the Q4 2013 impairment charge and the estimated tax impact of such charge.
March 31, March 31,
  2013     2012  
Current assets:
Cash and cash equivalents $ 105,999 $ 134,444
Restricted cash 5,488 1,962
Marketable securities 12,012 4,987
Accounts receivable, net 148,257 145,756
Inventories 710 1,242
Income taxes receivable - 2,628
Deferred income tax assets, net 12,140 10,127
Other current assets   12,720     11,563  
Total current assets 297,326 312,709
Equipment and improvements, net 21,887 17,841
Capitalized software costs, net 39,781 19,994
Intangibles, net 27,550 23,259
Goodwill 45,761 60,776
Other assets   10,750     5,773  
Total assets $ 443,055   $ 440,352  
Current liabilities:
Accounts payable $ 11,501 $ 4,532
Deferred revenue 65,207 83,108
Accrued compensation and related benefits 11,915 11,870
Income taxes payable 1,480 -
Dividends payable 10,418 10,354
Other current liabilities   26,508     19,568  
Total current liabilities 127,029 129,432
Deferred revenue, net of current 1,219 1,293
Deferred income tax liabilities, net - 5,351
Deferred compensation 3,809 3,497
Other noncurrent liabilities   3,949     5,602  
Total liabilities 136,006 145,175
Commitments and contingencies
Shareholders' equity:
Common stock
$0.01 par value; authorized 100,000 shares; issued and outstanding 59,543 and 59,180 shares at March 31, 2013 and March 31, 2012, respectively 595 592
Additional paid-in capital 179,743 169,033
Accumulated other comprehensive loss (11 ) (45 )
Retained earnings   126,722     125,597  
Total shareholders' equity   307,049     295,177  
Total liabilities and shareholders' equity $ 443,055   $ 440,352  




Three Months


Year Ended

March 31, 2013

March 31, 2013

Income (loss) before provision for income taxes $ (2,192 ) $ 68,914
Addback: Impairment of goodwill   17,400     17,400
15,208 86,314
Provision for income taxes (excluding tax effect of impairment)   2,916     27,208
Pro forma net income $ 12,292   $ 59,106
Pro forma net income per diluted share $ 0.21   $ 0.99



Quarterly Revenue $ 111,295
Times four (4) x   4
Equals Annualized Revenue 445,180
Divided by 365 days   365
Equals Average Daily Revenue = $ 1,220
Net Accounts Receivable $ 148,257
Divided by Average Daily Revenue   1,220
Equals Days Sales Outstanding =   122

Quality Systems, Inc.
Paul Holt, CFO
Susan J. Lewis

Source: Quality Systems, Inc.

News Provided by Acquire Media